120 related articles for article (PubMed ID: 14605803)
1. Pretransplant and early posttransplant predictors of chronic allograft nephropathy in cadaveric kidney allograft--a single-center analysis of 1112 cases.
Lietz K; Lewandowski Z; Lao M; Paczek L; Gaciong Z
Transpl Int; 2004 Feb; 17(2):78-88. PubMed ID: 14605803
[TBL] [Abstract][Full Text] [Related]
2. Posttransplant proteinuria is associated with higher risk of cardiovascular disease and graft failure in renal transplant patients.
Ibis A; Akgül A; Ozdemir N; Colak T; Sezer S; Arat Z; Haberal M
Transplant Proc; 2009 Jun; 41(5):1604-8. PubMed ID: 19545689
[TBL] [Abstract][Full Text] [Related]
3. Risk factors and prognosis for proteinuria in renal transplant recipients.
Sancho A; Gavela E; Avila A; Morales A; Fernández-Nájera JE; Crespo JF; Pallardo LM
Transplant Proc; 2007 Sep; 39(7):2145-7. PubMed ID: 17889119
[TBL] [Abstract][Full Text] [Related]
4. Comparative analysis of azathioprine versus cyclosporine-based therapy in primary haplo-identical live-donor kidney transplantation: a 20-year experience.
Gheith OA; Bakr MA; Fouda MA; Shokeir AA; Sobh M; Ghoneim M
Saudi J Kidney Dis Transpl; 2008 Jul; 19(4):564-70. PubMed ID: 18580014
[TBL] [Abstract][Full Text] [Related]
5. Serum C-reactive protein surge in renal transplant recipients: link with allograft survival.
Ozdemir NF; Elsurer R; Ibis A; Arat Z; Haberal M
Transplant Proc; 2007 May; 39(4):934-7. PubMed ID: 17524855
[TBL] [Abstract][Full Text] [Related]
6. Impact of Banff borderline acute rejection among renal allograft recipients.
Matoza JR; Danguilan RA; Chicano S
Transplant Proc; 2008 Sep; 40(7):2303-6. PubMed ID: 18790219
[TBL] [Abstract][Full Text] [Related]
7. Variable cyclosporine exposure: a risk factor for chronic allograft nephropathy and graft loss?
He X; Johnston A
Transplant Proc; 2004 Jun; 36(5):1321-6. PubMed ID: 15251323
[TBL] [Abstract][Full Text] [Related]
8. Long-term results in renal transplant patients with allograft dysfunction after switching from calcineurin inhibitors to sirolimus.
Bumbea V; Kamar N; Ribes D; Esposito L; Modesto A; Guitard J; Nasou G; Durand D; Rostaing L
Nephrol Dial Transplant; 2005 Nov; 20(11):2517-23. PubMed ID: 15985508
[TBL] [Abstract][Full Text] [Related]
9. Conversion from calcineurin inhibitor to sirolimus in pediatric chronic allograft nephropathy.
Falger JC; Mueller T; Arbeiter K; Boehm M; Regele H; Balzar E; Aufricht C
Pediatr Transplant; 2006 Jun; 10(4):474-8. PubMed ID: 16712606
[TBL] [Abstract][Full Text] [Related]
10. Three-year posttransplant graft survival in renal-transplant patients with graft function at 6 months receiving tacrolimus or cyclosporine microemulsion within a triple-drug regimen.
Irish W; Sherrill B; Brennan DC; Lowell J; Schnitzler M
Transplantation; 2003 Dec; 76(12):1686-90. PubMed ID: 14688516
[TBL] [Abstract][Full Text] [Related]
11. Characteristics of recipients whose kidney allograft has functioned for more than 20 years.
El-Agroudy AE; El-Dahshan KE; Abbass TM; Ismail AM; Shokeir AA; Ghoneim MA
Exp Clin Transplant; 2008 Jun; 6(2):155-60. PubMed ID: 18816244
[TBL] [Abstract][Full Text] [Related]
12. Transplanting kidneys from CMV-seropositive donors to CMV-seronegative recipients is not associated with poorer renal allograft function or survival.
McLaughlin K; Sandhu S; Wu C; Muirhead N; Hollomby D; Jevnikar A
Nephrol Dial Transplant; 2005 Jan; 20(1):176-80. PubMed ID: 15572381
[TBL] [Abstract][Full Text] [Related]
13. Determinants of graft survival in pediatric and adolescent live donor kidney transplant recipients: a single center experience.
El-Husseini AA; Foda MA; Shokeir AA; Shehab El-Din AB; Sobh MA; Ghoneim MA
Pediatr Transplant; 2005 Dec; 9(6):763-9. PubMed ID: 16269048
[TBL] [Abstract][Full Text] [Related]
14. Preemptive kidney transplant from deceased donors: an advantage in relation to reduced waiting list.
Pérez-Flores I; Sánchez-Fructuoso A; Calvo N; Marques M; Anaya S; Ridao N; Rodríguez A; Barrientos A
Transplant Proc; 2007 Sep; 39(7):2123-4. PubMed ID: 17889112
[TBL] [Abstract][Full Text] [Related]
15. A third renal transplantation: is it relevant and is it worth it?
Reboux AH; Kamar N; Fort M; Rischmann P; Malavaud B; Cointault O; Abbal M; Durand D; Rostaing L
Transplant Proc; 2005 Dec; 37(10):4199-202. PubMed ID: 16387077
[TBL] [Abstract][Full Text] [Related]
16. Impact of posttransplant diabetes mellitus on graft function in autosomal dominant polycystic kidney disease patients after kidney transplantation.
Pietrzak-Nowacka M; Safranow K; Dziewanowski K; Debska-Slizień A; Głyda M; Gołembiewska E; Jankowska M; Nowosiad M; Rutkowski B; Ciechanowski K
Ann Acad Med Stetin; 2008; 54(1):41-8. PubMed ID: 19127808
[TBL] [Abstract][Full Text] [Related]
17. Renal graft outcome in simultaneous kidney transplantation combined with other organs: experience of a single center.
Gutierrez-Baños J; Portillo J; Ballestero R; Zubillaga S; Ramos E; Campos J; Hidalgo E
Transplant Proc; 2008 Dec; 40(10):3424-7. PubMed ID: 19100404
[TBL] [Abstract][Full Text] [Related]
18. The impact of pretransplant cytomegalovirus infection on acute renal allograft rejection.
Chen JH; Mao YY; He Q; Wu JY; Lv R
Transplant Proc; 2005 Dec; 37(10):4203-7. PubMed ID: 16387078
[TBL] [Abstract][Full Text] [Related]
19. Early acute rejection does not affect chronic allograft nephropathy and death censored graft failure.
He X; Johnston A
Transplant Proc; 2004 Dec; 36(10):2993-6. PubMed ID: 15686679
[TBL] [Abstract][Full Text] [Related]
20. First year renal function as a predictor of kidney allograft outcome.
Resende L; Guerra J; Santana A; Mil-Homens C; Abreu F; da Costa AG
Transplant Proc; 2009 Apr; 41(3):846-8. PubMed ID: 19376368
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]